Current Report Filing (8-k)
01 April 2023 - 07:04AM
Edgar (US Regulatory)
ALPHA HEALTHCARE ACQUISITION CORP III
Units, each consisting of one share of Class Acommon stock, $0.0001
par value, and one-fourth of a redeemable Warrant to acquire one
share of Class A false 0001842939 0001842939 2023-03-29 2023-03-29
0001842939
alpa:UnitsEachConsistingOfOneShareOfClassAcommonStock0.0001ParValueAndOneFourthOfARedeemableWarrantToAcquireOneShareOfClassACommonStockMember
2023-03-29 2023-03-29 0001842939 us-gaap:CommonStockMember
2023-03-29 2023-03-29 0001842939
alpa:RedeemableWarrantsEachWholeWarrantExercisableForOneShareOfClassACommonStockAtAnExercisePriceOf11.50Member
2023-03-29 2023-03-29
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or Section 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): March 31,
2023 (March 29, 2023)
ALPHA
HEALTHCARE ACQUISITION CORP. III
(Exact name of registrant as specified in its charter)
|
|
|
|
|
Delaware |
|
001-40228 |
|
86-1645738 |
(State or other jurisdiction of
incorporation or organization)
|
|
(Commission
File Number)
|
|
(I.R.S. Employer
Identification Number)
|
|
|
|
1177 Avenue of the Americas, 5th Floor
New York, New York
|
|
10036 |
(Address of principal executive
offices) |
|
(Zip Code) |
(646) 494-3296
Registrant’s telephone number, including area code
N/A
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation to the registrant
under any of the following provisions:
☐ |
Written communications pursuant to Rule 425 under the Securities
Act (17 CFR 230.425)
|
☐ |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
|
☐ |
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR
240.14d-2(b))
|
☐ |
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR
240.13e-4(c))
|
Securities registered pursuant to Section 12(b) of the
Act:
|
|
|
|
|
Title of each class
|
|
Trading
Symbol(s)
|
|
Name of each exchange
on which registered
|
Units, each consisting of one share of Class A
common stock, $0.0001 par value, and one-fourth of a redeemable Warrant to
acquire one share of Class A common stock |
|
ALPAU |
|
The
NASDAQ Stock Market LLC |
Class A Common Stock, par value $0.0001 per share |
|
ALPA |
|
The
NASDAQ Stock Market LLC |
Redeemable Warrants, each whole warrant exercisable for one share
of Class A Common Stock at an exercise price of $11.50 |
|
ALPAW |
|
The
NASDAQ Stock Market LLC |
☒ Indicate by check mark whether the registrant is an
emerging growth company as defined in Rule 405 of the Securities
Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of
1934 (§240.12b-2 of this
chapter).
☐ If an emerging growth company, indicate by check mark
if the registrant has elected not to use the extended transition
period for complying with any new or revised financial accounting
standards provided pursuant to Section 13(a) of the Exchange
Act.
Item 3.01. |
Notice of Delisting or Failure to Satisfy a Continued Listing Rule
or Standard; Transfer of Listing.
|
On March 29, 2023, Alpha Healthcare Acquisition Corp. III (the
“Company”) received
a written notice (the “Notice”) from the Nasdaq Listing
Qualifications Department of The Nasdaq Stock Market (“Nasdaq”) indicating that the
Company was not in compliance with Listing Rule 5550(a)(3), which
requires the Company to have at least 300 public holders for
continued listing on the Nasdaq Capital Market (the “Minimum Public Holders Rule”).
The Notice is only a notification of deficiency, not of imminent
delisting, and has no current effect on the listing or trading of
the Company’s securities on Nasdaq Capital Market.
The Notice states that the Company has 45 calendar days to submit a
plan to regain compliance with the Minimum Public Holders Rule. If
the Company is unable to regain compliance by that date, the
Company intends to submit a plan to regain compliance with the
Minimum Public Holders Rule within the required timeframe. If
Nasdaq accepts Company’s plan, Nasdaq may grant the Company an
extension of up to 180 calendar days from the date of the Notice to
evidence compliance with the Minimum Public Holders Rule. If Nasdaq
does not accept the Company’s plan, the Company will have the
opportunity to appeal the decision in front of a Nasdaq Hearings
Panel.
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of
1934, the registrant has duly caused this report to be signed on
its behalf by the undersigned hereunto duly authorized.
Dated: March 31, 2023
|
|
|
ALPHA HEALTHCARE ACQUISITION CORP.
III |
|
|
By: |
|
/s/ Patrick A. Sturgeon
|
Name: |
|
Patrick A.
Sturgeon |
Title: |
|
Chief
Financial Officer |
Alpha Healthcare Acquisi... (NASDAQ:ALPAU)
Historical Stock Chart
From Aug 2023 to Sep 2023
Alpha Healthcare Acquisi... (NASDAQ:ALPAU)
Historical Stock Chart
From Sep 2022 to Sep 2023